Immunohistochemistry reagents assembled as a system, not a shelf of bottles

Building the stain

1. Optimise retrieval per antibody. Buffer, pH, temperature and duration each change epitope availability, and the optimum differs between reagents even on the same tissue. Optimise on tissue known to be positive and record the conditions with the protocol.
2. Block three things, not one. Endogenous peroxidase, endogenous biotin where a biotin system is used, and non specific protein binding are separate problems needing separate steps. Skipping any of them produces a characteristic background.
3. Prefer a polymer detection system where biotin is a problem. Polymer based detection removes the endogenous biotin question entirely and usually gives cleaner backgrounds in biotin rich tissues such as liver and kidney.
4. Choose the chromogen for the context. Chromogens differ in colour, in permanence and in whether they can be combined for multiplexing. A chromogen that fades or dissolves in the mounting medium ruins an archive.
5. Include the controls on the same slide where possible. A positive tissue, a negative tissue and a no primary control. Internal positive elements within the section are better still, because they experienced identical processing.
6. Fix the whole protocol before comparing sections. Fixation time, section thickness, retrieval, incubation times and temperature all change the result. Comparing sections processed differently compares processing.

Five layers, one result

Because the layers act in series, the weakest one determines the outcome, and troubleshooting that starts with the antibody usually starts in the wrong place. Working through retrieval, then blocking, then detection is faster.

Write the protocol as five named steps with their conditions. It makes the failure visible and the method transferable.

Fixation is set before you receive the block

Time to fixation, fixative and duration are decided by whoever collected the tissue, and they determine what any stain can show. Archival material of unknown fixation is a real limitation rather than a technical inconvenience.

Record what is known about fixation with each block, and be explicit in the write up where it is unknown.

Chromogenic or fluorescent, and why it matters

A chromogenic stain is read on a bright-field microscope, is stable for years, shows tissue architecture well and is hard to multiplex beyond two or three targets. A fluorescent stain multiplexes readily, quantifies better and fades, and it needs a suitable microscope and attention to autofluorescence.

Architecture and archival reading favour the first; co-localisation and multiplexing favour the second. Diagnostic practice is largely chromogenic for exactly those reasons, and research increasingly fluorescent for the opposite ones.

Retrieval is part of the antibody's validation

Cross-linking fixation hides epitopes, and unmasking them is done by heat in a buffer at a chosen pH or by a proteolytic enzyme. Heat suits most targets; enzymatic digestion suits some, particularly certain matrix and membrane antigens, and it damages morphology if over-applied.

Retrieval conditions are specific to the antibody and to the fixation, and they transfer poorly between laboratories. Establish them on control tissue, write them into the protocol, and treat a change of fixation as a reason to re-establish them.

Pathway markers report a flux you cannot see

A marker of a degradative pathway is present on structures that are continuously formed and consumed, so its level is the balance of both. An increase can mean more formation or less clearance, and those are opposite conclusions from the same stain.

Distinguishing them needs a blocking step, so that the marker's accumulation with clearance blocked reports the flux rather than the level, and ideally a second readout. A single stain reported as increased pathway activity is the standard over-interpretation here.

Modification-specific stains and sample handling

A stain for a phosphorylated form depends on the modification surviving from the moment the tissue left its blood supply. Warm ischaemic time before fixation changes these signals substantially, which is why surgical and autopsy material are not comparable.

Record the time to fixation and keep it constant, use a control tissue processed identically, and include a phosphatase-treated section as the negative. Without those, a difference between groups may be a difference in how the tissue was handled.

Validating a tissue antibody

Tissue staining is the application in which antibodies most often fail, because the epitope is fixed, folded and embedded in a complex background. The evidence is tissue known to express the target and tissue known not to, processed in the same run, with an isotype control at matched concentration.

For an ion channel, a secreted enzyme or a neuronal marker, published staining patterns in the same tissue are the reference to compare against. An antibody that produces a novel pattern is far more likely to be non-specific than to be revealing something new.

ihc reagents, and the chain a stain depends on

An immunohistochemistry stain is a chain of reagents and the weakest one shows on the slide: fixative and processing, which decide whether the epitope survives at all; the retrieval buffer, heat or enzyme; a block for endogenous peroxidase, biotin and non-specific binding; the primary antibody at a titrated dilution; a detection system, polymer or biotin-based; the chromogen; and the counterstain. Controls belong to the chain too, a known positive tissue and a no-primary section. Change one link and the protocol is re-titrated rather than transferred.

An immunohistochemistry kit, and what it saves

A kit bundles the detection system, usually a polymer or biotin-based secondary with a chromogen, plus blocking reagent and sometimes retrieval buffer, matched to each other and to a species of primary antibody. What it saves is the titration of the detection layer and the compatibility argument between reagents. What it does not save is the primary antibody's own titration, the controls, or the fixation and retrieval work. Read which primary hosts the kit supports and whether the chromogen suits the counterstain you use.

A citrate buffer and the retrieval it performs

A citrate buffer at pH 6 is the standard heat retrieval solution, and it recovers a different set of epitopes from the alkaline EDTA or Tris based alternatives, which is why a clone's datasheet names one rather than leaving it to the operator. Time at temperature matters as much as the buffer: over-retrieval lifts sections off the slide and under-retrieval leaves a clean negative that looks like an absent antigen.

10x tbs, and why the stock is made at that strength

10x tbs is kept as a concentrate because a wash buffer is consumed by the litre and a concentrate saves both storage and weighing errors, and the dilution is checked by pH after making up rather than assumed. Detergent is usually added to the working strength rather than the stock, since it foams and complicates measurement, and a stock kept too long grows contaminants that show as speckled background.

tris buffered saline against a phosphate wash

tris buffered saline is preferred over a phosphate wash wherever phosphate would interfere, which includes alkaline phosphatase detection and any step using a phosphate sensitive enzyme or a calcium containing reagent. For most immunostaining the two are interchangeable, and the reason to state which was used is reproducibility rather than performance. Ionic strength and pH are what a substitution has to match.

An ap substrate and the colour it deposits

An ap substrate for alkaline phosphatase detection is chosen by the colour and the solvent tolerance of the precipitate: one substrate gives a blue product that survives an alcohol dehydration, another gives a red product that does not and needs an aqueous mount. Endogenous phosphatase in tissue is blocked with levamisole, and the incubation is stopped by eye rather than by a fixed clock.

An alkaline phosphatase staining kit and what is in the box

An alkaline phosphatase staining kit packages the conjugate, the substrate and the buffers at a validated ratio, which is what a laboratory is paying for rather than the chemicals. The kit's own control slide is the part that makes a weak result interpretable. Where the tissue is rich in endogenous activity, the kit has to include or permit a block, and that is worth checking before the order.

Common questions

Why is my stain weak, and is it the primary antibody?

Retrieval, most often. In cross linked tissue the epitope has to be recovered, and the conditions differ between reagents. Optimise retrieval before increasing antibody concentration.

Where does high background come from?

Endogenous enzyme activity, endogenous biotin in a biotin based system, or insufficient protein blocking. Each has a distinct appearance and a distinct remedy, and adding more blocking protein does not fix the first two.

What controls does a section need?

A known positive, a known negative and a no primary control, ideally processed in the same run. Internal positive elements within the section are the strongest control because they saw identical conditions.

Chromogenic or fluorescent?

Chromogenic for architecture, archival stability and bright-field reading; fluorescent for multiplexing and quantification. The question, not the fashion, decides.

Does an increased pathway marker mean more activity?

Not on its own. Markers on structures that are continuously formed and consumed report a balance, so an increase can mean more formation or less clearance. A blocking step is what separates them.

Browse by service class

• Compare Gene synthesis on advertised prices